RecruitingPhase 2NCT07292272

Halt Aging in Survivors of Blood Cancers

Halt Aging in Survivors of Blood Cancers: the HALTAging-1 Study


Sponsor

University of Nebraska

Enrollment

180 participants

Start Date

Apr 9, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Older survivors of blood cancer are at a high risk of accelerated biological aging, which increases their risk of developing multiple aging-related conditions. Whereas physical exercise can improve overall health, older cancer survivors do not meet the recommended physical activity, highlighting the need to develop behavioral interventions to increase adherence. Several other knowledge gaps exist to implement exercise interventions in older survivors of blood cancer; the dose and duration of exercise necessary to slow biological aging in older blood cancer survivors remain unknown. To bridge these gaps in knowledge, we have designed a Phase 2 randomized control trial to test the effects of behavioral and exercise interventions on various outcomes.


Eligibility

Min Age: 50 Years

Inclusion Criteria3

  • Age ≥50 years
  • A history of hematological malignancy
  • Participants must be able to and willingly give informed consent

Exclusion Criteria7

  • Patients receiving intensive induction or consolidation chemotherapy. Maintenance chemotherapy, or lower-intensity chemotherapy for an indolent hematological malignancy is allowed.
  • Neurodegenerative disease (e.g. Alzheimer's dementia), stroke, or uncontrolled psychotic disorders (e.g. schizophrenia or bipolar disorder) in the past 3 months if those disorders are considered significant enough to impair participation in the study.
  • Illnesses such as clinical evidence of decompensated heart failure, unstable angina, or orthopedic or neuromuscular disorders that could limit safe participation in aerobic exercise.
  • Cardiopulmonary exercise test results that preclude safe exercise (e.g., life-threatening arrhythmia, balance difficulties, peak VO2 <10 ml/kg/min).
  • Estimated life expectancy of less than 6 months (that precludes assessment of study primary endpoint).
  • Self-reported pregnancy or the possibility of pregnancy.
  • Participants who do not plan to follow up at the participating center.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALBehavioral Coaching Intervention

Intervention arm incorporating virtually supervised moderate-intensity aerobic exercise and behavioral intervention/coaching to improve adherence

BEHAVIORALVirtual Exercise Platform

Access to a virtual exercise platform that provides exercise classes and educational sessions for older survivors of blood cancer


Locations(1)

University of Nebraska Medical Center

Omaha, Nebraska, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07292272


Related Trials